Many high-yield S&P 500 stocks are risky, but 19 'safer' dividend dogs have strong free cash flow to support payouts and are ...

TeraWulf's pivot to HPC hosting is proving successful, securing a $3.7B contract with Fluidstack, backed by Google. Read why ...

Vuzix is transitioning from technology validation to commercial viability. Check out why I am downgrading VUZI stock from Buy ...

Vistra's growth strategy is robust, with major acquisitions and nuclear license extensions supporting strong EBITDA targets ...

A growth-focused ETF offering tech-driven S&P 500 exposure. Ideal for long-term investors seeking capital gains.

ARM's renewed growth efforts are likely to be rather expensive, attributed to the intensified R&D investments and the ...

Williams upgraded at CIBC, which cites increasingly bullish natural gas demand trends and the outlook for infrastructure.

I rate Vistra Corp (VST) a Buy due to AI-driven power demand, robust fundamentals, and significant growth opportunities in ...

Cidara Therapeutics, Inc.'s CD388 shows promise as a superior flu prophylactic. Click for strong trial results, upcoming ...